Browse studies
Find your next paid study
16 recruiting studies matching your filters
Phase 1
An Early Phase 1 Trial to Assess Pharmacodynamic Effects of OMO-103 in Patients With Pancreatic Ductal Adenocarcinoma
This early phase I trial studies the biological activity of OMO-103 in patients with pancreatic ductal adenocarcinoma that has spread to nearby tissue or lymph…
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+2 more
Estimated
~$10 – $7,500
OHSU Knight Cancer InstituteNCT07089940
Phase 1
A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibito…
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Estimated
~$10 – $8,750
Revolution Medicines, Inc.NCT06445062
Phase 2
A Phase 2 Study Assessing Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
The purpose of this study is to understand whether a blood-based test called circulating tumor DNA (ctDNA) can detect whether participants are having a desired…
Metastatic Pancreatic Ductal AdenocarcinomaPancreatic Ductal Adenocarcinoma
Estimated
~$10 – $6,250
University of MiamiNCT07096362
Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer
This study evaluates an investigational scan called hyperpolarized carbon-13 pyruvate magnetic resonance imaging (MRI) in assessing treatment response in patie…
Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal Adenocarcinoma
Estimated
~$10 – $675
University of California, San FranciscoNCT06600906